摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(4-{3-[(3R)-3-aminopyrrolidinyl]propoxy}phenyl)ethanone | 392337-06-3

中文名称
——
中文别名
——
英文名称
1-(4-{3-[(3R)-3-aminopyrrolidinyl]propoxy}phenyl)ethanone
英文别名
1-[4-[3-[(3R)-3-aminopyrrolidin-1-yl]propoxy]phenyl]ethanone
1-(4-{3-[(3R)-3-aminopyrrolidinyl]propoxy}phenyl)ethanone化学式
CAS
392337-06-3
化学式
C15H22N2O2
mdl
——
分子量
262.352
InChiKey
PHNZBVSSQHIXIP-CQSZACIVSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.2
  • 重原子数:
    19
  • 可旋转键数:
    6
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.53
  • 拓扑面积:
    55.6
  • 氢给体数:
    1
  • 氢受体数:
    4

文献信息

  • 1,3-Disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications
    申请人:——
    公开号:US20020035103A1
    公开(公告)日:2002-03-21
    Compounds of formula I 1 are useful in treating diseases or conditions prevented by or ameliorated with histamine-3 receptor ligands. Also disclosed are histamine-3 receptor ligand compositions and methods of antagonizing or agonizing histamine-3 receptors.
    公式I1的化合物在治疗由组织胺-3受体配体防止或改善的疾病或病况中非常有用。还公开了组织胺-3受体配体组合物和拮抗或激动组织胺-3受体的方法。
  • 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications
    申请人:——
    公开号:US20020137931A1
    公开(公告)日:2002-09-26
    Compounds of formula I 1 are useful in treating diseases or conditions prevented by or ameliorated with histamine-3 receptor ligands. Also disclosed are histamine-3 receptor ligand compositions and methods of antagonizing or agonizing histamine-3 receptors.
    公式I1的化合物在治疗由组胺-3受体配体防止或改善的疾病或症状中很有用。还披露了组胺-3受体配体组合物和拮抗或激动组胺-3受体的方法。
  • [EN] 1,3-DISUBSTITUTED AND 1,3,3-TRISUBSTITUTED PYRROLIDINES AS HISTAMINE-3 RECEPTOR LIGANDS AND THEIR THERAPEUTIC APPLICATIONS<br/>[FR] PYRROLIDINES 1,3-DISUBSTITUEES ET 1,3,3-TRISUBSTITUEES UTILISEES COMME LIGANDS DU RECEPTEUR DE L'HISTAMINE-3 ET LEURS APPLICATIONS THERAPEUTIQUES
    申请人:ABBOTT LAB
    公开号:WO2002006223A1
    公开(公告)日:2002-01-24
    Compounds of formula (I) are useful in treating diseases or conditions prevented by or ameliorated with histamine-3 receptor ligands. Also disclosed are histamine-3 receptor ligand compositions and methods of antagonizing or agonizing histamine-3 receptors.
    I式化合物可用于治疗由组胺-3受体配体预防或改善的疾病或症状。还公开了组胺-3受体配体组合物以及拮抗或激动组胺-3受体的方法。
  • [EN] 1,3-DISUBSTITUTED AND 1,3,3,-TRISUBSTITUTED PYRROLIDINES AS HISTAMINE-3 RECEPTOR LIGANDS AND THEIR THERAPEUTIC APPLICATIONS<br/>[FR] PYRROLIDINES 1,3-DISUBSTITUEES ET 1,3,3,-TRISUBSTITUEES UTILISEES COMME LIGANDS DU RECEPTEUR DE L'HISTAMINE-3 ET APPLICATIONS THERAPEUTIQUES
    申请人:ABBOTT LAB
    公开号:WO2003059341A1
    公开(公告)日:2003-07-24
    Compounds of formula I, are useful in treating diseases or conditions prevented by or ameliorated with histamine-3 receptor ligands. Also disclosed are histamine-3 receptor ligand compositions and methods of antagonizing or agonizing histamine-3 receptors.
    式I的化合物可用于治疗由组胺-3受体配体预防或改善的疾病或病况。本发明还揭示了组胺-3受体配体组合物和拮抗或激动组胺-3受体的方法。
  • 1,3-DISUBSTITUTED AND 1,3,3-TRISUBSTITUTED PYRROLIDINES AS HISTAMINE-3 RECEPTOR LIGANDS AND THEIR THERAPEUTIC APPLICATIONS
    申请人:ABBOTT LABORATORIES
    公开号:EP1301480A1
    公开(公告)日:2003-04-16
查看更多